Lester Lee

Array ( [id] => 2596408 [patent_doc_number] => 04921835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-05-01 [patent_title] => 'Method of treating asthma' [patent_app_type] => 1 [patent_app_number] => 7/319972 [patent_app_country] => US [patent_app_date] => 1989-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2236 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/921/04921835.pdf [firstpage_image] =>[orig_patent_app_number] => 319972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2593061 [patent_doc_number] => 04933323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-06-12 [patent_title] => 'Novel peptide and salts thereof and peptide antiallergic agents containing these peptides' [patent_app_type] => 1 [patent_app_number] => 7/315285 [patent_app_country] => US [patent_app_date] => 1989-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4179 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/933/04933323.pdf [firstpage_image] =>[orig_patent_app_number] => 315285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2762517 [patent_doc_number] => 04994440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-02-19 [patent_title] => 'Method for the treatment of renal cell carcinoma' [patent_app_type] => 1 [patent_app_number] => 7/310256 [patent_app_country] => US [patent_app_date] => 1989-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2511 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/994/04994440.pdf [firstpage_image] =>[orig_patent_app_number] => 310256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2589237 [patent_doc_number] => 04963654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-16 [patent_title] => 'Peptide serine protease inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/309161 [patent_app_country] => US [patent_app_date] => 1989-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1422 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/963/04963654.pdf [firstpage_image] =>[orig_patent_app_number] => 309161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2746028 [patent_doc_number] => 05015633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-14 [patent_title] => 'Method for inhibiting loss of cognitive functions employing an ace inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/308293 [patent_app_country] => US [patent_app_date] => 1989-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 14069 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/015/05015633.pdf [firstpage_image] =>[orig_patent_app_number] => 308293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2670430 [patent_doc_number] => 05026686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-06-25 [patent_title] => 'Antiviral peptides' [patent_app_type] => 1 [patent_app_number] => 7/305148 [patent_app_country] => US [patent_app_date] => 1989-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2560 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/026/05026686.pdf [firstpage_image] =>[orig_patent_app_number] => 305148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2942611 [patent_doc_number] => 05254534 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-19 [patent_title] => 'Adjuvant for cancer immunotherapy' [patent_app_type] => 1 [patent_app_number] => 7/303219 [patent_app_country] => US [patent_app_date] => 1989-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5904 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/254/05254534.pdf [firstpage_image] =>[orig_patent_app_number] => 303219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2660139 [patent_doc_number] => 04978744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-12-18 [patent_title] => 'Synthesis of dolastatin 10' [patent_app_type] => 1 [patent_app_number] => 7/304572 [patent_app_country] => US [patent_app_date] => 1989-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 15569 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 522 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/978/04978744.pdf [firstpage_image] =>[orig_patent_app_number] => 304572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2648458 [patent_doc_number] => 04895931 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-23 [patent_title] => 'Phospholipase A.sub.2 -inhibiting peptides' [patent_app_type] => 1 [patent_app_number] => 7/301477 [patent_app_country] => US [patent_app_date] => 1989-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3993 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/895/04895931.pdf [firstpage_image] =>[orig_patent_app_number] => 301477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2626686 [patent_doc_number] => 04906612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-03-06 [patent_title] => 'Method for animal growth promotion using glyclopeptides' [patent_app_type] => 1 [patent_app_number] => 7/303745 [patent_app_country] => US [patent_app_date] => 1989-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4490 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/906/04906612.pdf [firstpage_image] =>[orig_patent_app_number] => 303745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2528006 [patent_doc_number] => 04861865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-08-29 [patent_title] => 'Novel antithrombin peptide' [patent_app_type] => 1 [patent_app_number] => 7/299576 [patent_app_country] => US [patent_app_date] => 1989-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2580 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/861/04861865.pdf [firstpage_image] =>[orig_patent_app_number] => 299576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2557305 [patent_doc_number] => 04897463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-01-30 [patent_title] => 'Biologically active peptides which inhibit toxoplasma multiplication' [patent_app_type] => 1 [patent_app_number] => 7/291039 [patent_app_country] => US [patent_app_date] => 1988-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4719 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/897/04897463.pdf [firstpage_image] =>[orig_patent_app_number] => 291039 [rel_patent_id] =>[rel_patent_doc_number] =>)